Document Type
Survey
Title
CSER Phase 2 Patient Reported Utility (PRU) of Clinical Sequencing Survey
Year:
Year
2019
The Patient Reported Utility (PRU) of Clinical Sequencing Survey asks participants to rate how useful they find nineteen outcomes of genome sequencing on a scale ranging from 1 (not at all useful) to 7 (extremely useful).
Research Population:
Research Population
Adults
Parents
Source
View online source